Kidney Transplantation
📧 Sign up to get email alerts when something new happens for Kidney Transplantation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Better Evidence for Selecting Transplant Fluids [Phase 3]
Phase 3 clinical trial update evaluating different fluids used during kidney transplantation to reduce complications, with the study status …
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Study of the Correlation Between Donor CIRBP and Transplanted Kidney Function
A completed clinical trial examining whether donor CIRBP levels correlate with transplanted kidney function.
-
CLINICAL_TRIALS trial_result · 2024-10-09Clinical Trial Update: Treg Modulation With CD28 and IL-6 Receptor Antagonists [Phase 1, Phase 2]
Phase 1/2 clinical trials evaluating regulatory T cell modulation using CD28 and IL-6 receptor antagonists in kidney transplant recipients h…
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Treg Therapy in Subclinical Inflammation in Kidney Transplantation [Phase 1, Phase 2]
Phase 1/2 trial evaluating regulatory T cell therapy for subclinical inflammation in adult living donor kidney transplant recipients; the st…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Transplant Regimen Adherence for Kidney Recipients by Engaging Information Technologies: The TAKE IT Trial [NA]
The TAKE IT Trial, evaluating IT-based methods to improve regimen adherence in kidney transplant recipients, has completed with results post…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Investigation of the Validity, Reliability, and Responsiveness of BETY-BQ in Chronic Kidney Disease, on Dialysis, and Kidney Transplantation
A study is investigating the validity, reliability, and responsiveness of BETY-BQ in chronic kidney disease, patients on dialysis, and kidne…
-
CLINICAL_TRIALS research · 2024-08-21Clinical Trial Update: Mycophenolate-Based Therapy for Kidney Transplant Recipients Without HLA-DQ Mismatch [Phase 4]
A Phase 4 clinical trial is evaluating a mycophenolate-based therapy for kidney transplant recipients without HLA-DQ mismatch; the study is …
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: rATG Versus rATG Combined With Intravenous Immunoglobulin (IVIG) Induction Immunosuppression in HLA Incompatible Transplantation (INHIBIT) [Phase 3]
A Phase 3 study comparing rATG alone versus rATG with IVIG for induction immunosuppression in HLA-incompatible kidney transplantation has co…
-
FDA approval · 2024-08-13FDA Approved: MYFORTIC — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for MYFORTIC (mycophenolic acid) from Novartis. The approval expands its use for preventing orga…
-
FDA approval · 2024-08-13FDA Approved: MYCOPHENOLIC ACID — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Mycophenolic Acid submitted by Aurobindo Pharma Limited under an ANDA, approving changes to …
-
FDA approval · 2024-08-13FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (ONESOURCE SPECIALTY PHARMA LIMITED)
FDA approved a supplemental application for mycophenolate mofetil submitted by Onesource Specialty Pharma Limited. The action pertains to ch…
-
FDA approval · 2024-08-13FDA Approved: MYCOPHENOLIC ACID — Supplemental Application (Biocon Pharma Inc.)
FDA approved Biocon Pharma Inc.'s supplemental application for mycophenolic acid, granting approval of the generic product under ANDA214630.…
-
CLINICAL_TRIALS research · 2024-07-19Clinical Trial Update: Manual Manipulation and Ex Vivo Flexible Ureteroscopic Lithotripsy to Salvage Deceased Donor Kidneys With Renal Stones: A Case Series
A case-series update on a new method using manual manipulation and ex vivo flexible ureteroscopic lithotripsy to salvage deceased donor kidn…
-
CLINICAL_TRIALS trial_result · 2024-07-17Clinical Trial Update: Envarsus on the Effect of Total Tacrolimus Dose/Trough Level Ratio on Renal Function (eGFR) in Kidney Transplantation [Phase 4]
Phase 4 study evaluating whether the ratio of total tacrolimus dose to trough level with Envarsus affects renal function (eGFR) in kidney tr…
-
CLINICAL_TRIALS trial_result · 2024-07-10Clinical Trial Update: Comparison of Tacrolimus Extended-Release (Envarsus XR) to Tacrolimus Immediate-Release in Human Leukocyte Antigen (HLA) Sensitized Kidney Transplant Recipients [Phase 4]
Phase 4 trial comparing tacrolimus extended-release (Envarsus XR) to immediate-release tacrolimus in HLA-sensitized kidney transplant recipi…
-
FDA approval · 2024-07-08FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (CONCORD BIOTECH LIMITED)
FDA approved a supplemental application for mycophenolate mofetil from Concord Biotech Limited, enabling approval of a generic formulation u…
-
CLINICAL_TRIALS trial_result · 2024-06-04Clinical Trial Update: FIH Phase I/IIa Trial Evaluating Safety of TUM012 to Minimize Ischemic Reperfusion Injury in Kidney Transplantation [Phase 1, Phase 2]
An early-phase (Phase I/IIa) clinical trial evaluating the safety of TUM012 to minimize ischemia-reperfusion injury in kidney transplantatio…
-
CLINICAL_TRIALS trial_result · 2024-06-03Clinical Trial Update: Quantify the Benefits of Biomarkers in Routine Patient Care in Kidney Transplant Recipients [NA]
A completed clinical trial update evaluates the benefits of using biomarkers in routine care for kidney transplant recipients. The study aim…
-
CLINICAL_TRIALS withdrawal · 2024-06-03Clinical Trial Update: Comparison of Tacrolimus and Myfortic Versus Tacrolimus and Sirolimus [Phase 4]
Phase 4 trial comparing tacrolimus with Mycophenolate mofetil versus tacrolimus with sirolimus for living donor kidney transplant patients h…
-
CLINICAL_TRIALS trial_result · 2024-05-31Clinical Trial Update: Impact of HLA Evolutionary Divergence and HLA Donor-recipient Molecular Mismatches on Kidney Allograft Rejection
A completed clinical trial evaluates whether HLA evolutionary divergence and donor–recipient molecular mismatches influence kidney allograft…
-
CLINICAL_TRIALS research · 2024-05-29Clinical Trial Update: DE NOVO DONOR SPECIFIC ANTIBODIES AFTER KIDNEY TRANSPLANTATION: SINGLE-CENTER RETROSPECTIVE STUDY
A single-center retrospective study examining de novo donor-specific antibodies after kidney transplantation.
-
CLINICAL_TRIALS trial_result · 2024-05-22Clinical Trial Update: Impact of Lymphocyte Anti-metabolite Immunosuppressions on Donor-Specific Anti-HLA Antibody and Kidney Graft Outcome [Phase 4]
Phase 4 clinical trial update evaluating the impact of lymphocyte anti-metabolite immunosuppressants on donor-specific anti-HLA antibodies a…
-
CLINICAL_TRIALS research · 2024-05-09Clinical Trial Update: Observation Study for Prediction of Allograft Survival and Impact of Imaging in Kidney Transplant Recipients.
This clinical trial update describes an observation study from the University of Liege to predict allograft survival and evaluate imaging in…
-
FDA approval · 2024-05-01FDA Approved: MYHIBBIN — Original Application (Azurity Pharmaceuticals, Inc.)
FDA approved MYHIBBIN, a mycophenolate mofetil product from Azurity Pharmaceuticals, under an original application (NDA216482). This approva…
-
CLINICAL_TRIALS withdrawal · 2024-02-28Clinical Trial Update: Introduction of mTor Inhibitors and the Activation of the Cytomegalovirus (CMV) -Specific Cellular Immune Response [Phase 4]
A Phase 4 clinical trial involving mTOR inhibitors and CMV-specific immune response in kidney transplantation has been withdrawn.